Gyre Therapeutics (GYRE) Short term Debt (2010 - 2016)
Gyre Therapeutics (GYRE) reported Short term Debt of $28000.0 for Q3 2016, down 95.86% year-over-year from $676000.0 in Q4 2015, and down 78.46% quarter-over-quarter from $130000.0 in Q2 2016.
Gyre Therapeutics (GYRE) Short term Debt (2010 - 2016) Analysis & Trends
Gyre Therapeutics (GYRE) has 7 years of Short term Debt data on file, last reported at $28000.0 in Q3 2016.
- Short term Debt for Q3 2016 came in at $28000.0, down 95.86% year-over-year; the trailing twelve-month figure through Sep 2016 was $28000.0 (down 95.86% YoY), and the FY2015 annual result was $1.2 million, changed N/A from the prior year.
- Short term Debt retreated to $28000.0 in Q3 2016 per GYRE's latest filing, from $130000.0 in the prior quarter.
- Over five years, Short term Debt peaked at $1.2 million in Q4 2015 and troughed at $28000.0 in Q3 2016.
- A 5-year average of $690625.0 and a median of $847500.0 in 2012 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2015 and 2016: Short term Debt jumped 41.42% in 2015, then sank 95.86% in 2016.
- A 5-year view of Short term Debt shows it stood at $851000.0 in 2012, then rose by 0.24% to $853000.0 in 2013, then slumped by 43.96% to $478000.0 in 2014, then soared by 141.84% to $1.2 million in 2015, then slumped by 97.58% to $28000.0 in 2016.
- Business Quant data shows GYRE's Short term Debt at $28000.0 in Q3 2016, $130000.0 in Q2 2016, and $196000.0 in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Gyre Therapeutics | 554.75 Mn | 540.62 Mn | 8.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 28,000.00 |
| Jun 30, 2016 | 130,000.00 |
| Mar 31, 2016 | 196,000.00 |
| Dec 31, 2015 | 1.16 Mn |
| Sep 30, 2015 | 676,000.00 |
| Sep 30, 2014 | 478,000.00 |
| Jun 30, 2014 | 699,000.00 |
| Mar 31, 2014 | 776,000.00 |
| Dec 31, 2013 | 853,000.00 |
| Sep 30, 2013 | 873,000.00 |
| Jun 30, 2013 | 866,000.00 |
| Mar 31, 2013 | 858,000.00 |
| Dec 31, 2012 | 851,000.00 |
| Sep 30, 2012 | 844,000.00 |
| Jun 30, 2012 | 870,000.00 |
| Mar 31, 2012 | 896,000.00 |
| Dec 31, 2011 | 1.24 Mn |
| Sep 30, 2011 | 1.59 Mn |
| Jun 30, 2011 | 1.91 Mn |
| Dec 31, 2010 | 1.71 Mn |